Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DICER: Dipyridamole in COVID-19
NCT04391179Phase 2Completed
- Sponsor
- University of Michigan
- Start
- May 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Dipyridamole with Placebo (2 arms). Primary endpoint: Percent Change in D-dimer at 14 days. Started May 2020; status: completed.
02
Drugs
dipyridamole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04391179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04391179.